| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
3-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl)acrylamide manufacturers
- GR 46611
-
- $84.00
-
2026-09-10
- CAS:185259-85-2
- Purity: 99.90%
- Supply Ability: 10g
|
| | 3-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl)acrylamide Basic information |
| Product Name: | 3-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl)acrylamide | | Synonyms: | GR 46611;3-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-[(4-methoxyphenyl)methyl]prop-2-enamide;2-Propenamide, 3-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-[(4-methoxyphenyl)methyl]-;GR 46611, 5-HT1B/1D agonist;3-[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]-N-[(4-methoxyphenyl)methyl]-2-propenamide;3-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl)acrylamide | | CAS: | 185259-85-2 | | MF: | C23H27N3O2 | | MW: | 377.48 | | EINECS: | | | Product Categories: | | | Mol File: | 185259-85-2.mol | ![3-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl)acrylamide Structure](CAS/GIF/185259-85-2.gif) |
| | 3-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl)acrylamide Chemical Properties |
| Boiling point | 645.9±55.0 °C(Predicted) | | density | 1.168 | | storage temp. | 2-8°C | | solubility | DMSO: 28 mg/mL, soluble | | pka | 14.51±0.46(Predicted) | | form | solid | | color | white |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | WGK Germany | 3 |
| | 3-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl)acrylamide Usage And Synthesis |
| Uses | GR 46611is a 5-HT1D agonist. | | Definition | ChEBI: 3-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-[(4-methoxyphenyl)methyl]-2-propenamide is a member of tryptamines. | | Biological Activity | 5-HT 1D receptor agonist. Blockade of GR 46611-induced hypothermia in the guinea pig provides a useful model with which to study the potency and duration of action of centrally acting 5-HT 1D receptor ligands. | | in vivo | GR-46611 (1 mg/kg, i.p. ) significantly improves survival of Dravet syndrome (DS) mice[1].
GR-46611 (0.03-300 μg/kg, i.v.) increases threshold volume, bladder capacity, and residual volume in chronic spinal cord injury (SCI) cats[3].
GR46611 (3-30 mg/kg, s.c.) causes a dose-related decrease in rectal temperature in the adult guinea-pig[4].
| Animal Model: | Dravet syndrome (DS) mice[1] | | Dosage: | 0.01, 0.1 and 1 mg/kg | | Administration: | Intraperitoneal injection (i.p.) | | Result: | Improved survival relative to vehicle treated controls with 89% surviving rate. |
| | IC 50 | 5-HT1D Receptor |
| | 3-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl)acrylamide Preparation Products And Raw materials |
|